Hyperopia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age between 6 and 35 years; 2.Spherical equivalent refractive error (manifest refraction) of both eyes ranging from +3.00 D to –7.00 D; 3.Best-corrected visual acuity (BCVA) >= 0.8; 4.Normal anterior segment examination in both eyes, with clear corneas and normal pupillary light reflexes; 5.Able to cooperate with and complete the ophthalmic examination procedures.
Exclusion criteria
Exclusion criteria: 1.Patients with ocular diseases that may affect refractive measurements or constitute a contraindication to mydriasis, including but not limited to glaucoma, iridocyclitis, active ocular inflammation, severe corneal pathology, cataract, lens dislocation, and any significant retinal or optic nerve disease (such as retinal detachment, optic atrophy, etc.); 2.Patients with a history of intraocular surgery (e.g., cataract, glaucoma, or vitreoretinal surgery) or corneal refractive surgery; 3.Patients currently (e.g., within the past month) using medications that may affect ocular accommodation, pupil size, or vascular status, such as atropine or pirenzepine eye drops, systemic anticholinergic drugs, sympathomimetic agents, etc.; 4.Patients with a known allergy to any component of the mydriatic agents used in the study; 5.Patients with severe systemic diseases (such as uncontrolled hypertension, serious cardiovascular disease, hyperthyroidism, epilepsy, asthma, etc.) that make it unsafe to perform mydriasis or to cooperate with the examinations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Axial length;Cycloplegic refraction;Wide-field retinal refraction ;Choroidal Blood Flow;Choroidal thickness; | — |
Countries
China
Contacts
Changsha Aier Eye Hospital, Aier Eye Hospital Group Co., Ltd.